SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-118157
Filing Date
2024-04-26
Accepted
2024-04-26 16:27:59
Documents
14
Period of Report
2024-04-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d799173d8k.htm   iXBRL 8-K 29222
2 EX-10.1 d799173dex101.htm EX-10.1 30263
  Complete submission text file 0001193125-24-118157.txt   192489

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA veru-20240424.xsd EX-101.SCH 2847
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE veru-20240424_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE veru-20240424_pre.xml EX-101.PRE 11259
17 EXTRACTED XBRL INSTANCE DOCUMENT d799173d8k_htm.xml XML 3620
Mailing Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127
Business Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

IRS No.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-13602 | Film No.: 24884274
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)